CV

CVS Health Corp

CVS
Accountable AI Logo

CVS Health Corp AI Insights

Informational only. Not investment advice.
As of 2025-12-08

Snapshot

  • 5.7B impairment charge TTM crushed net income to 469M (0.1% margin) - masks 10.8B operating income pre-charges[Impairment of Capital Assets]
  • Goodwill of 85.5B is 117% of equity - tangible book value is negative 38.5B, creating impairment overhang[Goodwill]
  • Debt/equity 1.12x with 81.8B total debt vs 6.3B FCF TTM - 13 years to deleverage at current pace[Debt to Equity]

Watch Triggers

  • Impairment of Capital Assets: Additional charges >2B in next 12 monthsSignals Aetna/Caremark synergies failing; could trigger covenant concerns
  • Operating Margin TTM: Falls below 2%Margin compression would extend deleveraging timeline beyond sustainable
  • Free Cash Flow TTM: Drops below 5BThreatens 2.66/share dividend (3.4B annual) and debt paydown capacity

Bull Case

Revenue scale of 394B with 1.55x asset turnover generates 6.3B FCF despite thin 0.1% net margin - operational leverage intact

Total Revenue TTMAsset Turnover TTMFree Cash Flow TTM

P/E 22x on depressed earnings; P/S 0.25x is 6x cheaper than 1.5x industry median - priced for permanent impairment

PE RatioPS Ratio

Bear Case

81.8B debt with 3.1B interest expense consumes 49% of operating income; 13-year deleveraging timeline limits flexibility

Total DebtInterest Expense TTMDebt to Equity

Negative tangible equity (-38.5B) means additional goodwill writedowns directly impair solvency ratios

Tangible Book ValueGoodwillImpairment of Capital Assets

Bull vs Bear Balance

AI-generated sentiment analysis based on fundamental metrics and market conditions.

BearBull
40%

Leverage CVS's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.

Take Me to The Editor

Forward Thesis

Normalized earnings power of 8-10B annually once impairments cease

1-3ymed
  • Operating income 10.8B TTM before 5.7B impairment
  • Interest expense 3.1B manageable at current debt levels
  • FCF 6.3B despite working capital drag of 1.6B
Operating margin 2.7% vs 2% industry medianCash flow from ops 9.1B TTMAsset turnover 1.55x vs 0.79x median

Goodwill impairment risk remains elevated given negative tangible equity

3-12mhigh
  • 85.5B goodwill from Aetna/Caremark acquisitions
  • Healthcare segment margin pressure industry-wide
  • Already took 5.7B impairment TTM
Tangible book value -38.5BGoodwill 117% of stockholders equityP/B ratio negative at -2.5x
Valuation Context
Caveats

Public Strategies Rankings

See how CVS Health Corp ranks across different investment strategies.

Leverage CVS's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.

Data Partners
Morningstar Logo

Fundamental company data provided by Morningstar, updated daily.

Accountable Finance, Inc. Disclaimer
accountable.finance is not operated by a broker or a dealer. Under no circumstances does any information posted on accountable.finance represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. In no event shall accountable.finance be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on accountable.finance, or relating to the use of, or inability to use, accountable.finance or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Stock quotes and fundamental company data provided by Morningstar, updated daily.

Accountable Logo
© 2025 Accountable Finance, Inc. All rights reserved.